Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

126 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of Helicobacter pylori eradication on gastro-oesophageal reflux.
Tefera S, Hatlebakk JG, Berstad A. Tefera S, et al. Aliment Pharmacol Ther. 1999 Jul;13(7):915-20. doi: 10.1046/j.1365-2036.1999.00544.x. Aliment Pharmacol Ther. 1999. PMID: 10383526
Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up.
Berstad A, Berstad K, Wilhelmsen I, Hatlebakk JG, Nesje LB, Hausken T. Berstad A, et al. Aliment Pharmacol Ther. 1995 Apr;9(2):197-200. doi: 10.1111/j.1365-2036.1995.tb00371.x. Aliment Pharmacol Ther. 1995. PMID: 7605862 Clinical Trial.
[10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
Berstad A, Berstad K, Hatlebakk JG, Wilhelmsen I, Nysaeter G, Bang CJ, Hausken T, Nesje LB, Hjartholm AS, Hundal O. Berstad A, et al. Tidsskr Nor Laegeforen. 1994 Sep 10;114(21):2477-9. Tidsskr Nor Laegeforen. 1994. PMID: 7940447 Norwegian.
[Prokinetics in reflux disease. Action mechanisms and clinical effects].
Hatlebakk JG, Berstad A. Hatlebakk JG, et al. Tidsskr Nor Laegeforen. 1994 Feb 28;114(6):689-92. Tidsskr Nor Laegeforen. 1994. PMID: 8191452 Review. Norwegian.
Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.
Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekström P, Halvorsen L, Stallemo A, Hovdenak N, Trondstad R, et al. Hatlebakk JG, et al. Scand J Gastroenterol. 1993 Mar;28(3):224-8. doi: 10.3109/00365529309096076. Scand J Gastroenterol. 1993. PMID: 8446846 Clinical Trial.
Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
Berstad A, Hatlebakk JG. Berstad A, et al. Aliment Pharmacol Ther. 1993;7 Suppl 1:34-6, discussion 61-6. doi: 10.1111/j.1365-2036.1993.tb00586.x. Aliment Pharmacol Ther. 1993. PMID: 8490077 Review.
The predictive value of symptoms in gastro-oesophageal reflux disease.
Berstad A, Hatlebakk JG. Berstad A, et al. Scand J Gastroenterol Suppl. 1995;211:1-4. doi: 10.3109/00365529509090284. Scand J Gastroenterol Suppl. 1995. PMID: 8545622
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S, Berstad A, Bang CJ, Nysaeter G, Hatlebakk JG, Olafsson S, Nesje LB, Hausken T, Berstad K, Hundal O. Tefera S, et al. Am J Gastroenterol. 1996 May;91(5):935-41. Am J Gastroenterol. 1996. PMID: 8633584 Clinical Trial.
Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
Berstad A, Hatlebakk JG, Wilhelmsen I, Berstad K, Bang CJ, Nysaeter G, Hausken T, Weberg R, Nesje LB, Hjartholm AS. Berstad A, et al. Hepatogastroenterology. 1995 Sep-Oct;42(5):655-9. Hepatogastroenterology. 1995. PMID: 8751230
126 results
Jump to page
Feedback